Obligasi Berkelanjutan II Pyridam Farma Tahap II Tahun 2026

Rating: irA- (KRI) Pharma Turnaround Hits Operating Breakeven as Pyridam Terms Out Its 2027 Maturity PT Pyridam Farma Tbk (IDX: PYFA) is an integrated pharmaceutical group, founded in 1976 and listed in 2001, spanning prescription medicines, consumer health, esthetics, medical devices and contract manufacturing (CDMO) across Indonesia and Australia. It has expanded since 2021 through […]
